Serina Therapeutics Statistics
Total Valuation
SER has a market cap or net worth of $60.57 million. The enterprise value is $65.66 million.
Important Dates
The last earnings date was Friday, August 9, 2024, after market close.
| Earnings Date | Aug 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SER has 8.88 million shares outstanding. The number of shares has decreased by -15.81% in one year.
| Shares Outstanding | 8.88M |
| Shares Change (YoY) | -15.81% |
| Shares Change (QoQ) | +264.05% |
| Owned by Insiders (%) | 31.41% |
| Owned by Institutions (%) | 4.87% |
| Float | 2.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.59 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71
| Current Ratio | 0.71 |
| Quick Ratio | 0.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.51 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -45.29% |
| Return on Capital (ROIC) | -252.55% |
| Revenue Per Employee | $288,409 |
| Profits Per Employee | -$637,013 |
| Employee Count | 11 |
| Asset Turnover | 0.31 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.57% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -70.57% |
| 50-Day Moving Average | 7.21 |
| 200-Day Moving Average | 9.99 |
| Relative Strength Index (RSI) | 41.65 |
| Average Volume (20 Days) | 12,095 |
Short Selling Information
The latest short interest is 27,518, so 0.31% of the outstanding shares have been sold short.
| Short Interest | 27,518 |
| Short Previous Month | 32,704 |
| Short % of Shares Out | 0.31% |
| Short % of Float | 0.94% |
| Short Ratio (days to cover) | 1.73 |
Income Statement
In the last 12 months, SER had revenue of $3.17 million and -$7.01 million in losses. Loss per share was -$1.74.
| Revenue | 3.17M |
| Gross Profit | -1.04M |
| Operating Income | -7.41M |
| Pretax Income | -890,146 |
| Net Income | -7.01M |
| EBITDA | -7.27M |
| EBIT | -7.41M |
| Loss Per Share | -$1.74 |
Full Income StatementBalance Sheet
The company has $6.06 million in cash and $11.71 million in debt, giving a net cash position of -$5.65 million or -$0.64 per share.
| Cash & Cash Equivalents | 6.06M |
| Total Debt | 11.71M |
| Net Cash | -5.65M |
| Net Cash Per Share | -$0.64 |
| Equity (Book Value) | -16.39M |
| Book Value Per Share | -1.86 |
| Working Capital | -3.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.49 million and capital expenditures -$203,015, giving a free cash flow of -$10.69 million.
| Operating Cash Flow | -10.49M |
| Capital Expenditures | -203,015 |
| Free Cash Flow | -10.69M |
| FCF Per Share | -$1.20 |
Full Cash Flow StatementMargins
Gross margin is -32.68%, with operating and profit margins of -233.50% and -220.87%.
| Gross Margin | -32.68% |
| Operating Margin | -233.50% |
| Pretax Margin | -221.72% |
| Profit Margin | -220.87% |
| EBITDA Margin | -229.06% |
| EBIT Margin | -233.50% |
| FCF Margin | -85.98% |